Tag Archives: Gordon Broderick

Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression

Posted on 05/20/2019 by wames

Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression

Endocrine immune regulation in… women with CFS

Posted on 04/24/2019 by wames

Leveraging prior knowledge of endocrine immune regulation in the therapeutically relevant phenotyping of women with Chronic Fatigue Syndrome, by Matthew C Morris, Katherine Cooney, Hooman Sedghamiz, Maria Abreu, Fanny Collado, Elizabeth G Balbin, Travis JA Craddock, Nancy G Klimas, Gordon … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Endocrine immune regulation in… women with CFS

Pharmaceutical interventions in CFS: a literature-based commentary

Posted on 03/21/2019 by wames

Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary, by  Spencer Richman, Matthew C Morris, Gordon Broderick, Travis JA Craddock, Nancy G Klimas, Mary Ann Fletcher in Clinical Therapeutics [Available online 11 March 2019] Research abstract: Myalgic encephalomyelitis/chronic fatigue syndrome … Continue reading →

Posted in News | Tagged , , , , , , , | Comments Off on Pharmaceutical interventions in CFS: a literature-based commentary